The Clorox Company (NYSE:CLX) Expects Q2 2025 Earnings of $1.56 per Share

The Clorox Company (NYSE:CLX – Free Report ) – Equities research analysts at Zacks Research cut their Q2 2025 earnings per share (EPS) estimates for Clorox in a report issued on Wednesday, August 14th. Zacks Research analyst R. Lohia now forecasts that the company will post earnings of $1.56 per share for the quarter, down from their prior estimate of $1.61. The consensus estimate for Clorox’s current full-year earnings is $6.40 per share. Zacks Research also issued estimates for Clorox’s Q3 2025 earnings at $1.73 EPS, Q4 2025 earnings at $1.91 EPS, Q3 2026 earnings at $1.81 EPS and Q4 2026 earnings at $1.84. EPS.

A number of other equities analysts recently weighed in on the company. TD Cowen assumed coverage on Clorox in a research report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target on the stock. Barclays upped their target price on Clorox from $122.00 to $130.00 and gave the stock an “underweight” rating in a research report on Monday, August 5th. Citigroup cut their price target on Clorox from $150.00 to $145.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 10th. JPMorgan Chase & Co. decreased their target price on Clorox from $150.00 to $148.00 and set a “neutral” rating on the stock in a research report on Friday, August 2nd. Finally, BNP Paribas began coverage on Clorox in a research report on Monday, June 24th. They issued an “underperform” rating and a $130.00 target price on the stock. Six equities research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. Clorox currently has a consensus rating of “Hold” and a consensus price target of $141.94, according to MarketBeat.

Check out our latest report on Clorox

Clorox Price Performance

Shares of NYSE CLX opened at $145.40 on Monday. The company’s 50-day moving average price is $136.47, and its two-hundred-day moving average price is $142.39. The company has a market cap of $18.06 billion, a PE ratio of 75.34, a price-to-earnings-growth ratio of 1.97 and a beta of 0.39. The company has a quick ratio of 0.53, a current ratio of 0.90, and a debt-to-equity ratio of 9.73. Clorox has a 12-month low of $114.68 and a 12-month high of $158.89.

Hedge funds hurt Clorox

A number of institutional investors have recently modified their holdings of the business. Vanguard Group Inc. raised its holdings in shares of Clorox by 0.3% in the first quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock worth $2,339,150,000 after buying an additional 48,632 shares during the last quarter. Nuance Investments LLC boosted its holdings in shares of Clorox by 150.6% during the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after buying an additional 960,094 shares in the last quarter. Van ECK Associates Corp boosted its holdings in shares of Clorox by 1,715.5% during the second quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock worth $199,411,000 after purchasing an additional 1,380,724 shares during the last quarter. Point72 Asset Management LP acquired a new position in shares of Clorox in the 4th quarter worth $144,844,000. Finally, Bank of New York Mellon Corp grew its holdings in shares of Clorox by 14.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock worth $131,200,000 , after buying an additional 120,716 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s shares.

Clorox is raising dividends

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th will be given a $1.22 dividend. This is a positive change from Clorox’s previous quarterly dividend of $1.20. The ex-dividend date is Tuesday, August 13. This represents an annualized dividend of $4.88 and a dividend yield of 3.36%. Clorox’s dividend payout ratio (DPR) is currently 252.85%.

Clorox Company Profile

(Get a free report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle and International. The Health and Wellness segment offers cleaning products such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell and Rainbow Light brands in the United States.

Read more

Get news and reviews for Clorox Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Clorox and related companies with MarketBeat.com’s FREE daily email newsletter.